DONATE →

Oncology research

Strongers editorial cover for clinical study NCT03600701 (Phase II), status: active, not recruiting — Recurrent Lung Non-Small Cell Carcinoma. Oncology research

Clinical trial NCT03600701 · Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma

NCT03600701 — is «active, not recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-525303-27-00 (Phase II), status: authorised — Non-small cell lung cancer (NSCLC). Oncology research

Clinical trial 2026-525303-27-00 · Non-small cell lung cancer (NSCLC)

2026-525303-27-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Ricercatore al microscopio in laboratorio oncologico, intento ad analizzare campioni per lo studio della resistenza tumorale Oncology research

ALK-positive lung cancer: what happens when targeted therapy stops working

Targeted therapies have transformed ALK-positive lung cancer, but over time the tumour can find ways to resist. Here, in...

Read more
Strongers editorial cover for clinical study NCT06422546, status: recruiting — Non Small Cell Lung Cancer. Oncology research

Clinical trial NCT06422546 · Non Small Cell Lung Cancer

NCT06422546 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-526300-67-00 (Phase III), status: authorised — Locally Advanced, Unresectable Non-Small Cell Lu. Oncology research

Clinical trial 2026-526300-67-00 · Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III)

2026-526300-67-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT04198766 (Phase I/II), status: recruiting — Resectable Non-Small-Cell Lung Cancer. Oncology research

Clinical trial NCT04198766 · Non-Small Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer

NCT04198766 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT04613596 (Phase II/III), status: recruiting — Advanced Non-Small Cell Lung Cancer. Oncology research

Clinical trial NCT04613596 · Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

NCT04613596 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-526043-36-00 (Phase II), status: authorised — advanced NSCLC. Oncology research

Clinical trial 2026-526043-36-00 · advanced NSCLC

2026-526043-36-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT05086692 (Phase I/II), status: active, not recruiting — Non-Small Cell Lung Cancer Squamous. Oncology research

Clinical trial NCT05086692 · Non-Small Cell Lung Cancer Squamous, Non-Small Cell Lung Cancer Non-squamous

NCT05086692 — is «active, not recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT07063745 (Phase II/III), status: recruiting — Metastatic Non-small Cell Lung Cancer With MTAP. Oncology research

Clinical trial NCT07063745 · Metastatic Non-small Cell Lung Cancer With MTAP Deletion

NCT07063745 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-525268-16-00 (Phase II), status: authorised — Non Small Cell Lung Cancer. Oncology research

Clinical trial 2026-525268-16-00 · Non Small Cell Lung Cancer

2026-525268-16-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT06561386 (Phase III), status: recruiting — Non-small Cell Lung Cancer. Oncology research

Clinical trial NCT06561386 · Non-small Cell Lung Cancer

NCT06561386 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT06810544 (Phase I/II), status: recruiting — Non Small Cell Lung Cancer. Oncology research

Clinical trial NCT06810544 · Non Small Cell Lung Cancer, Non-Small Cell Adenocarcinoma

NCT06810544 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2025-524079-22-00 (Phase III), status: authorised — KRAS G12D-mutated Locally Advanced (Unresectable. Oncology research

Clinical trial 2025-524079-22-00 · KRAS G12D-mutated Locally Advanced (Unresectable) or Metastatic Non-small Cell Lung Cancer (NSCLC)

2025-524079-22-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT06066138 (Phase I), status: recruiting — Locally Advanced Non Small Cell Lung Cancer. Oncology research

Clinical trial NCT06066138 · Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer

NCT06066138 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT07554339 (Phase III), status: recruiting — Non-small Cell Lung Cancer. Oncology research

Clinical trial NCT07554339 · Non-small Cell Lung Cancer

NCT07554339 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2025-522058-38-00 (Phase II), status: authorised — HER2 positive non-small cell lung cancer. Oncology research

Clinical trial 2025-522058-38-00 · HER2 positive non-small cell lung cancer

2025-522058-38-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Giovane ricercatrice al microscopio in laboratorio oncologico, simbolo della precision oncology sul cancro al polmone Oncology research

Precision Oncology and Lung Cancer: how sport-funded research is changing therapeutic perspectives

Lung cancer is the leading cause of cancer-related death worldwide. Strongers funds NSCLC research with mini-grants for...

Read more
Strongers editorial cover for clinical study NCT06623422 (Phase III), status: recruiting — Carcinoma, Non-Small-Cell Lung. Oncology research

Clinical trial NCT06623422 · Carcinoma, Non-Small-Cell Lung

NCT06623422 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-526866-26-00 (Phase IV), status: authorised — Non-small cell lung cancer (NSCLC) and Head and. Oncology research

Clinical trial 2026-526866-26-00 · Non-small cell lung cancer (NSCLC) and Head and neck squamous cell carcinoma

2026-526866-26-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT04267848 (Phase III), status: recruiting — Lung Non-Small Cell Squamous Carcinoma. Oncology research

Clinical trial NCT04267848 · Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma

NCT04267848 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT07670312 (Phase I/II), status: recruiting — Non-Small Cell Lung Cancer. Oncology research

Clinical trial NCT07670312 · Non-Small Cell Lung Cancer

NCT07670312 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT05132075 (Phase III), status: active, not recruiting — Non-Small Cell Lung Cancer. Oncology research

Clinical trial NCT05132075 · Non-Small Cell Lung Cancer

NCT05132075 — is «active, not recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2025-524439-38-00 (Phase II), status: authorised — Non Small Cell Lung Cancer (NSCLC). Oncology research

Clinical trial 2025-524439-38-00 · Non Small Cell Lung Cancer (NSCLC)

2025-524439-38-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT07224152 (Phase I/II), status: recruiting — Locally-Advanced Non-Small Cell Lung Cancer. Oncology research

Clinical trial NCT07224152 · Locally-Advanced Non-Small Cell Lung Cancer

NCT07224152 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-525170-19-00 (Phase II), status: authorised — Locally Advanced or Metastatic Non-Small Cell Lu. Oncology research

Clinical trial 2026-525170-19-00 · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

2026-525170-19-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT05920356 (Phase III), status: recruiting — Non-Small Cell Lung Cancer (NSCLC). Oncology research

Clinical trial NCT05920356 · Non-Small Cell Lung Cancer (NSCLC)

NCT05920356 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study 2026-526251-60-00 (Phase II), status: authorised — Unresectable stage III non-small cell lung cance. Oncology research

Clinical trial 2026-526251-60-00 · Unresectable stage III non-small cell lung cancer

2026-526251-60-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Read more
Strongers editorial cover for clinical study NCT07361562 (Phase I), status: recruiting — Non-Small Cell Lung Cancer. Oncology research

Clinical trial NCT07361562 · Non-Small Cell Lung Cancer

NCT07361562 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT06667908 (Phase II), status: recruiting — Carcinoma, Non-Small-Cell Lung. Oncology research

Clinical trial NCT06667908 · Carcinoma, Non-Small-Cell Lung

NCT06667908 — is «recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT05949606 (Phase I/II), status: active, not recruiting — Non-small Cell Lung Cancer. Oncology research

Clinical trial NCT05949606 · Non-small Cell Lung Cancer

NCT05949606 — is «active, not recruiting» on ClinicalTrials.gov.

Read more
Strongers editorial cover for clinical study NCT02194738, status: active, not recruiting — Stage IIIA Lung Non-Small Cell Cancer AJCC v7. Oncology research

Clinical trial NCT02194738 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7

NCT02194738 — is «active, not recruiting» on ClinicalTrials.gov.

Read more

A newsletter for those who compete, those who donate, those who believe in research

Events, awarded grants, stories of the people who make research possible. One email a month, no spam.